Björnsson E, Johansson L, Martínez F. "一种的合成方法" [P]. European Patent, EP 3825873 A1, 2020-01-27.
Lefèvre J P, Kowalski A, Jørgensen K. "Method for the Synthesis of 2-(2-Chloroethyl)-5-methylpyrazine" [P]. European Patent, EP 3558614 A1, 2024-02-28.
Klinger H, Lee S K, Roberts E F. "A Process for Preparing High-Purity 2-(2-Chloroethyl)-5-methylpyrazine" [P]. US Patent, US 10774836 B2, 2015-01-06.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2014, 1257, (3), 8475-8480.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2025, 920, (11), 5962-5989.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of 2-(2-Chloroethyl)-5-methylpyrazine Using HRMS and NMR". Biomed. Chromatogr., 2024, 1330, 8028-8044.